Aspirin resistance: Position paper of the working group on aspirin resistance

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 6, 2005, Pages 1309-1311

  Michelson, Allan D ^a,b,k   Cattaneo, M ^c   Eikelboom, J W ^d   Gurbel, P ^e   Kottke Marchant, K ^f   Kunicki, T J ^g   Pulcinelli, F M ^h   Cerletti, C ⁱ   Rao, A K ^j  

^a International Society on Thrombosis and Haemostasis   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Center for Platelet Function Studies   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COLLAGEN RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FIBRINOGEN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; THROMBOXANE A2; THROMBOXANE RECEPTOR; THROMBOXANE SYNTHASE;

ACETYLATION; BIOAVAILABILITY; CELL INTERACTION; DRUG ABSORPTION; DRUG MECHANISM; DRUG RESPONSE; ENDOTHELIUM CELL; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; REVIEW; SHEAR FLOW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STRESS; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; TREATMENT FAILURE; TREATMENT REFUSAL; ARTICLE; CONSENSUS; DRUG EFFECT; DRUG RESISTANCE; VASCULAR ENDOTHELIUM;

ASPIRIN; BLOOD PLATELETS; CONSENSUS; DRUG RESISTANCE; ENDOTHELIUM, VASCULAR; HUMANS; THROMBOSIS;

EID: 24944474901     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01351.x     Document Type: Review

References (7)

1. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 2004; 126: 234S-64.
2. Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993; 71: 397-03.
3. Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlboeck M, Schreiner W, Losert U, Wolner E. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-7.
4. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5.
5. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Amer Coll Cardiol 2003; 41: 961-5.
6. Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Amer Coll Cardiol 2004; 43: 1122-6.
7. Grundmann K, Jaschonek K, Kleine B, Dichgans J, Topka H. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 2003; 250: 63-6.